Global Drug Discovery Market Assessment, By Drug Type [Small Molecules and Biologics], By Source [Natural and Synthetic], By Technology [Combinatorial chemistry, High-throughput screening, Nanotechnology, Pharmacogenomics, and Other Technologies], By End-user [Pharmaceutical Companies, Contract Research Organizations and Others], By Region, Opportunities and Forecast, 2017-2031F
Global Drug Discovery Market size was valued at USD 68.24 billion in 2023 which is expected to reach USD 154.12 billion in 2031 with a CAGR of 10.72% for the forecast period between 2024 and 2031F.
Home>Industry Reports>Global Drug Discovery Market Assessment, Opportunities and Forecast, 2017-2031F
Global drug discovery market size was valued at USD 68.24 billion in 2023, which is expected to reach USD 154.12 billion in 2031, with a CAGR of 10.72% for the forecast period between 2024 and 2031F. Growth in global drug discovery market is driven by various factors such as rising prevalence of various chronic diseases, increasing healthcare expenditure, patent expiration of certain popular drugs, adoption of AI solutions, and increasing investments in private and public sector in the biomedical research.
The global drug discovery market is further undergoing robust growth due to an increase in the elderly population. Decrease in fertility rates, increase in life expectancy due to an increase in healthcare facilities, and vast treatment options available worldwide for the elderly population are the factors helping people to live longer. However, it has further accelerated age-related modalities and chronic diseases among the population. To combat these modalities, innovation and research & development in drug discovery are needed. Moreover, each country has its own set of regulations that are responsible to check the safety and efficacy of the approved drug to ensure and maintain the quality and standard of the drug at every step to improve the health of the population.
The COVID-19 pandemic has accelerated the movement of care resulting in increased healthcare expenditure across different countries. The increased healthcare expenditure has surged in global drug discovery market due to increased spending on research, drug development, and manufacturing process. Drug discovery is an expensive, complex, and sensitive process that requires funding from the government and pharmaceutical industry, due to the costs and risks associated with pharmaceutical R&D. Healthcare spending results in better provision of health opportunities that further strengthens the healthcare system of a country and simultaneously leads to the growth of global drug discovery market.
Increasing Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a major driving factor for the global drug discovery market. According to WHO, chronic diseases including cardiovascular diseases, cancer, diabetes, and respiratory illnesses are responsible for 41 million deaths every year at global level. It affects people of all age groups, irrespective of their region and countries. Unhealthy diet, sedentary lifestyle, tobacco use, and alcohol abuse are the leading risk factors for the rising chronic diseases in developing as well as developed countries. The increasing prevalence is further propelling the demand for new drug discoveries. To achieve the goal of a healthier future, pharmaceutical companies are accelerating research and development for discovering new medicines. Drug discoveries are required to treat symptoms of new diseases, chronic diseases, untreatable diseases, and to solve the issue of drug resistance. As life expectancy is increasing, people are more prone to getting exposed to these diseases, resulting in growth of global drug discovery market.
Increased Investments in Drug discovery
Significant public and private investments are needed to support the manufacturing of drugs, whether they are small molecule drugs, protein-based biologic drugs, vaccines, or in vivo diagnostics. These investments by the organizations is thriving the global drug discovery market to meet the global healthcare goals. With increase in chronic diseases and new diseases encounters, the need for developing and discovering new drugs to tackle the health issues of the growing population is the need of the hour. To meet this demand, many biotech companies in USA, Europe, and APAC have raised big investments in drug discoveries.
For instance, in September 2023, Generate Biomedicines raised USD 273 million in a Series C round to advance its generative AI pipeline of preclinical and clinical protein therapeutics. In the same month September 2023, Grit Biotechnology raised USD 60 million in a Series B round. Grit Biotechnology has its specialization in the field of tumor immunotherapy, and this investment will further support its tumor-infiltrating lymphocyte (TIL) pipeline development in the future. Hence, these investments in the drug developing process are expected to accelerate the global drug discovery market.
Government Initiatives
Drug discovery is a time consuming and expensive process and requires funds and support from the government on its various manufacturing steps. The Government has devoted billions for drug discovery R&D. The expenditure has covered a variety of activities such as discovering and testing new drugs, developing innovations, and clinical testing for safety-monitoring purpose. Government has launched many initiatives, policies, and programs to help and support global drug discovery market. For instance, according to an article published by US Government Accountability Office (GAO) on September 2023, The National Institutes of Health (NIH) has identified many viral families that have the potential to cause future pandemics. To combat these viral diseases there is a need to develop antiviral drugs. GAO has identified some technologies like artificial intelligence to speed up antiviral drug development process. In 2022, the White House issued the National Biodefense Strategy and Implementation Plan to support this agenda of antiviral drugs development.
Growing Demand for Biologics
There has been a notable surge in demand for biologics in the global drug discovery market. The category of Biologics is gaining momentum due to its huge potential to treat diseases, which are considered untreatable or difficult to treat. Biologics have attributes that makes them more specific to treat the targeted disease and are less likely to react with other drugs. Hence, they ensure safety of the patients who are taking multiple drugs. These attributes have resulted in an upsurge in demand for biologics and many countries, including Japan, the United Kingdom, India, China, the United States, and Sweden, beginning to develop complex biomanufacturing facilities to meet this rising demand. Major pharmaceutical corporations are entering the biologics space, for instance, in September 2023, Takeda Pharmaceuticals, Inc. got approval from Center for Biologics Evaluation and Research (CBER) for biologics named ADZYNMA, which is indicated for prophylactic or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP).
Use of AI in Drug Discovery
Drug development is a long, complex, and uncertain process that takes an average of 10-12 years to develop. The pharmaceutical industry is trying to create a fast and effective solution for drug development, and hence, companies are applying various computational methods to reach that goal. A novel technology called computer-aided drug design, or CADD, is used in the drug discovery process to find and develop a possible lead. Molecular modelling, molecular design, rational drug design and computational chemistry are all part of CADD. The use of AI can simplify and facilitate drug design by filtering datasets available. With the use of healthcare related data available in the records along with latest innovation in AI and Machine learning, it is possible to analyze the data and use it for faster and accurate outcomes. Thus, we can say that use of AI in drug discovery is further accelerating the global drug discovery market.
Many companies are using AI in their drug development process, for instance, on November 21, 2023, Genentech, a member of the Roche Group announced a multi-year strategic research collaboration with NVIDIA to use artificial intelligence (AI) to speed up drug discovery and development. NVIDIA and Genentech collaboration will help Genentech’s AI/ML teams, to leverage AI and ML foundational models across numerous research areas including diverse therapeutic modalities as well as will help in gaining new insights, promoting growth in the global drug discovery market.
Future Market Scenario
Global drug discovery market is expected to grow in the coming years, due to multiple factors. Primarily, the increasing global aging population has led to a higher incidence of chronic illnesses such as cardiovascular diseases, cancer, diabetes, respiratory illness, and many more. Additionally, growth in the development of biosimilars and increased use of AI by the drugs manufacturing companies is further propelling the growth in the global drug discovery market. Other important driving factors are governmental support, policies, increase in healthcare expenditure and pharmaceutical regulatory agencies and organizations. The regulatory bodies maintain the safety and efficacy of the newly approved drug by thoroughly examining the drug manufacturing process. Collaborative ventures involving pharmaceutical companies, research institutions, and biotechnology firms have spurred innovation.
Report Scope
“Global Drug Discovery Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, which provides an in-depth analysis and qualitative and quantitative assessment of the current state of global drug discovery market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, future market scenario, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
In this report, global drug discovery market has been segmented into the following categories:
· By Drug Type
o Small Molecules
o Biologics
· By Source
o Natural
o Synthetic
· By Technology
o Combinatorial chemistry
o High-throughput screening
o Nanotechnology
o Pharmacogenomics
o Other Technologies
· By End-user
o Pharmaceutical Companies
o Contract Research Organizations
o Others
· By Region
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
Key Players Landscape and Outlook
In the drug discovery market, companies progressively establish strategic partnerships and distribution agreements, which plays a pivotal role in market expansion. These alliances empower firms to harness each other's strengths, gain access to new markets and technologies, and pool resources for research and development endeavors. Distribution agreements enable companies to broaden their market presence at an international level. These collaborative initiatives promote innovation, expedite product development, and contribute to robust growth in the drug discovery market. In September 2023, Ono Pharmaceutical Co., Ltd., a Japanese firm announced that it has entered into a drug discovery collaboration agreement with Adimab, LLC., which is a global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies. The collaboration aims to discover and develop innovative antibody drugs in the oncology field.
Key Players Operating in Global Drug Discovery Market are:
· Johnson & Johnson Inc.
· F. Hoffmann-La Roche Ltd.
· Pfizer Inc.
· Novartis AG
· Merck & Co., Inc.
· Amgen, Inc.
· Eli Lilly and Company
· AbbVie Inc.
· GlaxoSmithKline plc.
· Bristol Myers Squibb
· Sanofi Winthrop Industrie
· AstraZeneca Plc.
Markets and Data report answers the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for global drug discovery market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Future Outlook of Global Drug Discovery Market
4. Executive Summary
5. Global Drug Discovery Market Outlook, 2017-2031F
5.1. Market Size & Forecast
5.1.1.Value
5.1.2.Volume
5.2. By Drug Type
5.2.1.Small Molecules
5.2.2.Biologics
5.3. By Source
5.3.1.Natural
5.3.2.Synthetic
5.4. By Technology
5.4.1.Combinatorial chemistry
5.4.2.High-throughput screening
5.4.3.Nanotechnology
5.4.4.Pharmacogenomics
5.5. By End-user
5.5.1.Pharmaceutical Companies
5.5.2.Contract Research Organizations
5.5.3.Others
5.6. By Region
5.6.1.North America
5.6.2.Europe
5.6.3.South America
5.6.4.Asia-Pacific
5.6.5.Middle East and Africa
5.7. By Company Market Share (%), 2023
6. Global Drug Discovery Market Outlook, By Region, 2017-2031F
6.1. North America*
6.1.1. Market Size & Forecast
6.1.1.1. Value
6.1.1.2. Volume
6.1.2.2. Biologics
6.1.3.1. Natural
6.1.3.2. Synthetic
6.1.4. By Technology
6.1.4.1. Combinatorial chemistry
6.1.4.2. High-throughput screening
6.1.4.3. Nanotechnology
6.1.4.4. Pharmacogenomics
6.1.4.5. Other Technologies
6.1.5. By End-user
6.1.5.1. Pharmaceutical Companies
6.1.5.2. Contract Research Organizations
6.1.5.3. Others
6.1.6. United States*
6.1.6.1. Market Size & Forecast
6.1.6.1.1. Value
6.1.6.1.2. Volume
6.1.6.2. By Drug Type
6.1.6.2.1. Small Molecules
6.1.6.2.2. Biologics
6.1.6.3. By Source
6.1.6.3.1. Natural
6.1.6.3.2. Synthetic
6.1.6.4. By Technology
6.1.6.4.1. Combinatorial chemistry
6.1.6.4.2. High-throughput screening
6.1.6.4.3. Nanotechnology
6.1.6.4.4. Pharmacogenomics
6.1.6.4.5. Other Technologies
6.1.6.5. By End-user
6.1.6.5.1. Pharmaceutical Companies
6.1.6.5.2. Contract Research Organizations
6.1.6.5.3. Others
6.1.7. Canada
6.1.8. Mexico
*All segments will be provided for all regions and countries covered
6.2. Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 United Kingdom
6.2.5 Russia
6.2.6 Netherlands
6.2.7 Spain
6.2.8 Turkey
6.2.9 Poland
6.3. South America
6.3.1. Brazil
6.3.2. Argentina
6.4. Asia Pacific
6.4.1. India
6.4.2. China
6.4.3. Japan
6.4.4. Australia
6.4.5. Vietnam
6.4.6. South Korea
6.4.7. Indonesia
6.4.8. Philippines
6.5. Middle East & Africa
6.5.1. Saudi Arabia
6.5.2. UAE
6.5.3. South Africa
7. Market Mapping, 2023
7.1. By Drug Type
7.2. By Source
7.3. By Technology
7.4. By End-user
7.5. By Region
8. Macro Environment and Industry Structure
8.1. Supply Demand Analysis
8.2. Import Export Analysis
8.3. Value Chain Analysis
8.4. PESTEL Analysis
8.4.1. Political Factors
8.4.2. Economic System
8.4.3. Social Implications
8.4.4. Technological Advancements
8.4.5. Environmental Impacts
8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
8.5. Porter’s Five Forces Analysis
8.5.1. Supplier Power
8.5.2. Buyer Power
8.5.3. Substitution Threat
8.5.4. Threat from New Entrant
8.5.5. Competitive Rivalry
9. Market Dynamics
9.1. Growth Drivers
9.2. Growth Inhibitors (Challenges and Restraints)
10. Regulatory Framework and Innovation
10.1 Clinical Trials
10.2 Patent Landscape
10.3 Regulatory Approvals
10.4 Innovations/Emerging Technologies
11. Key Players Landscape
11.1. Competition Matrix of Top Five Market Leaders
11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4. SWOT Analysis (For Five Market Players)
11.5. Patent Analysis (If Applicable)
12. Pricing Analysis
13. Case Studies
14. Key Players Outlook
14.1.1. Company Details
14.1.2. Key Management Personnel
14.1.3. Products & Services
14.1.4. Financials (As reported)
14.1.5. Key Market Focus & Geographical Presence
14.1.6. Recent Developments
14.2. F. Hoffmann-La Roche Ltd.
14.3. Pfizer Inc.
14.4. Novartis AG
14.5. Merck & Co., Inc.
14.6. Amgen, Inc.
14.7. Eli Lilly and Company
14.8. AbbVie Inc.
14.9. GlaxoSmithKline plc.
14.10. Bristol Myers Squibb
14.11. Sanofi Winthrop Industrie
14.12. AstraZeneca Plc.
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
15. Strategic Recommendations
16. About Us & Disclaimer
List of Figures
Figure 1. Global Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 3. Global Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 4. Global Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 5. Global Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 6. Global Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 7. Global Drug Discovery Market Share (%), By Region, 2017-2031F
Figure 8. North America Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 10. North America Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 11. North America Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 12. North America Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 13. North America Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 14. North America Drug Discovery Market Share (%), By Country, 2017-2031F
Figure 15. United States Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 17. United States Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 18. United States Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 19. United States Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 20. United States Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 23. Canada Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 24. Canada Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 25. Canada Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 26. Canada Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 29. Mexico Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 30. Mexico Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 31. Mexico Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 32. Mexico Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 35. Europe Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 36. Europe Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 37. Europe Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 38. Europe Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Drug Discovery Market Share (%), By Country, 2017-2031F
Figure 40. Germany Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 42. Germany Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 43. Germany Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 44. Germany Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 45. Germany Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 46. France Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 48. France Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 49. France Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 50. France Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 51. France Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 54. Italy Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 55. Italy Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 56. Italy Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 57. Italy Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 60. United Kingdom Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 61. United Kingdom Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 62. United Kingdom Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 63. United Kingdom Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 66. Russia Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 67. Russia Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 68. Russia Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 69. Russia Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 72. Netherlands Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 73. Netherlands Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 74. Netherlands Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 75. Netherlands Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 78. Spain Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 79. Spain Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 80. Spain Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 81. Spain Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 84. Turkey Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 85. Turkey Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 86. Turkey Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 87. Turkey Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 90. Poland Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 91. Poland Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 92. Poland Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 93. Poland Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 94. South America Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 96. South America Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 97. South America Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 98. South America Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 99. South America Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 100. South America Drug Discovery Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 103. Brazil Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 104. Brazil Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 105. Brazil Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 106. Brazil Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 109. Argentina Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 110. Argentina Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 111. Argentina Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 112. Argentina Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 115. Asia-Pacific Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 116. Asia-Pacific Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 117. Asia-Pacific Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 118. Asia-Pacific Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Drug Discovery Market Share (%), By Country, 2017-2031F
Figure 120. India Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 122. India Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 123. India Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 124. India Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 125. India Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 126. China Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 128. China Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 129. China Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 130. China Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 131. China Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 134. Japan Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 135. Japan Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 136. Japan Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 137. Japan Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 140. Australia Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 141. Australia Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 142. Australia Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 143. Australia Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 146. Vietnam Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 147. Vietnam Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 148. Vietnam Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 149. Vietnam Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 152. South Korea Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 153. South Korea Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 154. South Korea Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 155. South Korea Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 158. Indonesia Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 159. Indonesia Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 160. Indonesia Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 161. Indonesia Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 164. Philippines Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 165. Philippines Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 166. Philippines Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 167. Philippines Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 170. Middle East & Africa Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 171. Middle East & Africa Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 172. Middle East & Africa Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 173. Middle East & Africa Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Drug Discovery Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 177. Saudi Arabia Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 178. Saudi Arabia Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 179. Saudi Arabia Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 180. Saudi Arabia Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 183. UAE Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 184. UAE Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 185. UAE Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 186. UAE Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Drug Discovery Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Drug Discovery Market, By Volume, In Million, 2017-2031F
Figure 189. South Africa Drug Discovery Market Share (%), By Drug Type, 2017-2031F
Figure 190. South Africa Drug Discovery Market Share (%), By Source, 2017-2031F
Figure 191. South Africa Drug Discovery Market Share (%), By Technology, 2017-2031F
Figure 192. South Africa Drug Discovery Market Share (%), By End-user, 2017-2031F
Figure 193. By Drug Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Source Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
Who are the key players operating in global drug discovery market?
What are the major factors influencing the growth of global drug discovery market?
What are the regions covered in the final report of global drug discovery market?
What is the market size and growth rate of global drug discovery market?
See Related Reports
Global Coffee Market Assessment, Opportunities and Forecast, 2017-2031F
Global coffee market is expected to experience growth due to consumers’ increasing preference for organic and premium coffee that offers freshness, superior quality of beans and roasts, and unique flavor profile. Additionally, the product innovation,....Read More
Published on
July 2024
4,500
Global Home Theater System Market Assessment, Opportunities and Forecast, 2017-2031F
Global home theater system market is expected to experience growth due to technological advancements, increasing disposable incomes, rising demand for high-definition content, integration with smart home systems, and the surge in streaming services p....Read More
Published on
July 2024
4,500
Global Baby Food Market Assessment, Opportunities and Forecast, 2017-2031F
Global baby food market is expected to experience growth due to factors such as consumers’ increasing awareness of the nutrients which are essential for babies development and introduction of wide variety of baby foods in the market from milk powders....Read More
Published on
July 2024
4,500
Global Isoflavones Market Assessment, Opportunities and Forecast, 2017-2031F
Global isoflavones market is expected to experience growth due to increasing consumer health awareness, rising demand for functional foods and nutraceuticals, advancements in extraction technologies, and expanding applications in cosmetics, pharmaceu....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
